Look for CRISPR/Cas9 to Treat Eye Diseases First, Scientists Say

Feb 04, 2016

|

This is the fourth article in an in-depth series on the impact of CRISPR/Cas9 genome editing technology on basic and clinical research, the biotechnology industry, and the world at large. The first installment, on the development of the CRISPR toolkit, can be found here.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Aiming for the Mutations

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Why in Decline?

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Time Off and a Connection

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

Genome Research Papers Examine Epigenetic Aging and Method to ID CNVs

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.